Octavio Espinoza, CFO: Ligand Pharmaceuticals LGND Sell · Filed 25/12/16

Trade details

Type: Insider sale
Amount: $339,711.24
Shares · price: 1,804 sh · $188.31 a share
Held after: 26,186 sh
Stock: Ligand Pharmaceuticals LGND
Person: Octavio EspinozaCFO
Trade date: 25/12/12
Filed: 25/12/16
Days to filing: 4 days

Sold 6.4% of holdings

Share of holding sold: 6.4%

Ligand Pharmaceuticals trades, last 26 weeks

What else happened in Ligand Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/11/12~01/11

Octavio Espinoza's recent trades

Octavio EspinozaCFO
Planned sale10b5-1 planLigand Pharmaceuticals
Planned sale10b5-1 plan
Ligand Pharmaceuticals
LGND
$9.1M
31,641 sh
$9.1M
Filed 08/12
Traded 08/12
Octavio EspinozaCFO
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$687.8K
3,057 sh
$687.8K
Filed 03/13
Traded 03/11
Octavio EspinozaCFO
Planned sale10b5-1 planLigand Pharmaceuticals
Planned sale10b5-1 plan
Ligand Pharmaceuticals
LGND
$649K
3,057 sh
$649K
Filed 03/11
Traded 03/11
Octavio EspinozaCFO
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$712.6K
3,413 sh
$712.6K
Filed 03/06
Traded 03/04
Octavio EspinozaCFO
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$510.8K
2,457 sh
$510.8K
Filed 03/06
Traded 03/04

Octavio Espinoza, CFO — sold $339.7K of Ligand Pharmaceuticals LGND · 6.4% of holdings | Whalegun